Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone with Epidural Steroid Injection for Low Back Pain
NCT03418649Phase 4Withdrawn
- Sponsor
- University of Cincinnati
- Start
- Jun 2023
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in degenerative disc disease (DDD), Sciatic radiculopathy, sponsored by University of Cincinnati. Planned start Jun 2023; status: withdrawn.
02
Drugs
eplerenone
03
Conditions
degenerative disc disease (DDD)Sciatic radiculopathy
Beyond the preview
Go deeper on NCT03418649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418649.